Non-small cell lung cancer

• A Clinical Study to Evaluate the Safety and Pharmacokinetics of JNJ- 73841937 (Lazertinib), a Third Generation EGFR-TKI, as Monotherapy or i … Recruitment ended
  2023-506577-35-00 3 2020-09-08 "Advanced Non-Small Cell Lung Cancer"
• Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200) Recruitment ended
  2023-508214-42-00 5 2020-05-25 "Previously treated locally advanced and unresectable or meta"
• Study of U3-1402 in subjects with non-small cell lung cancer Recruitment ended
  2024-511205-33-00 3 2020-05-18 "METASTATIC OR UNRESECTABLE NON-SMALL CELL LUNG CANCER"
• ABP - Advancing Brigatinib Properties in anaplastic lymphoma kinase positive nonsmall cell lung cancer (ALK+ NSCLC) patients by deep phenoty … Recruitment ended
  2024-513947-94-00 4 2020-03-30 "locally advanced (stage III) and not suitable for curative t"
• Trastuzumab Deruxtecan, and pembrolizumab in participants with Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer Recruitment ended
  2023-509866-39-00 3 2020-02-14 "Locally advanced/metastatic breast or non-small cell lung ca"
• A trial to learn if different cancer treatment combinations are safe and work in people with advanced non-small cell lung cancer that has mu … Recruitment ended
  2023-504624-25-00 4 2019-09-26 "Advanced Non-Small Cell Lung Cancer"
• A Phase 3, Randomized, Double-blind Study of Chemotherapy plus Nivolumab versus Chemotherapy plus Placebo provided before surgery, followed … Recruitment ended
  2022-502658-15-00 5 2019-09-22 "Resectable Stage II-IIIB Non-small cell lung cancer"
• An open label, multicenter extension study in patients previously enrolled in a Genentch and/or F. Hoffmann-La Roche Ltd sponsored atezolizu … Recruitment ended
  2023-506184-34-00 5 2019-08-09 "Advanced Malignancies"
• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specifi … Recruitment ended
  2024-511798-31-00 7 2019-05-31 "KRAS p.G12C Mutant Advanced Solid Tumors"
• Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell … Recruitment ended
  2023-507902-15-00 4 2019-03-26 "Non-Small Cell Lung Cancer"
• A Study of Durvalumab Before and After Surgery for Patients with Operable Non-Small Cell Lung Cancer. Recruitment ended
  2023-509576-42-00 5 2019-02-21 "Patients with resectable Non-small Cell Lung Cancer (Stage I"
• Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors Recruitment ended
  2023-503812-34-00 4 2019-02-13 "Locally Advanced or Metastatic Disease in Solid Tumors"
• Chemo +/- Pembrolizumab (MK-3475) as Perioperative Therapy for Stage II, IIIA-Resectable IIIB (N2) NSCLC Recruitment ended
  2023-504820-24-00 5 2018-03-21 "Neoadjuvant/Adjuvant treatment for participants with Resecta"
• A Phase 1/2 study on the effects of LOXO-292 (study drug) in patients with advanced solid tumors. Recruitment ended
  2023-507702-13-00 7 2017-09-22 "Male or female patients age 12 years or older with a locally"
• An Extension and Long-Term Observational Study In Patients Previously Enrolled in a Genentech− and/Or F. Hoffmann-La Roche Ltd−Sponsored Ate … Recruitment ended
  2023-506186-57-00 5 2017-09-04 "Cancer (Future parent protocols may include other cancer tha"
• „INSIGHT“ An explorative, open-labeled, phase I trial to evaluate feasibility and safety of eftilagimod alpha (IMP321, a LAG-3Ig fusion prot … Recruitment ended
  2024-516026-56-00 3 2017-08-17 "Histologically confirmed locally advanced or metastatic soli"
• Study with investigational drug PF-06463922 and comparator crizotinib in patients with a specific type of advanced lung cancer Recruitment ended
  2023-509169-19-00 5 2017-07-11 "Advanced ALK positive non-small cell lung cancer"
• A study for patients who have completed a prior global Novartis sponsored ceritinib (LDK378) study and are judged by the investigator to ben … Recruitment ended
  2024-511040-58-00 6 2016-01-12 "non small cell lung cancer"
• A clinical study to evaluate the efficacy of ceritinib in combination with nivolumab in patients with ALK positive lung cancer Recruitment ended
  2024-510824-38-00 3 2015-05-27
• A study to evaluate novel immunotherapy combinations in participants with advanced non-small cell lung cancer (NSCLC) Halted
  2023-508730-34-00 9 2024-07-10 "Non-small cell lung cancer (NSCLC): - Locally advanced NSCLC"
• A study of PF-08046050 (SGN-CEACAM5C) in adults with advanced solid tumors Halted
  2023-505858-18-00 1 2024-06-28 "Pancreatic carcinoma"
• Study of efficacy and safety of JDQ443 single-agent as first-line treatment for patients with locally advanced or metastatic KRAS G12C- muta … Halted
  2024-511708-18-00 4 2022-12-06 "Locally advanced or metastatic KRAS G12C-mutated non-small c"
• Study of efficacy and safety of JDQ443 in comparison with docetaxel in participants with locally advanced or metastatic KRAS G12C mutant non … Halted
  2023-510082-10-00 5 2022-09-05 "Advanced non-small cell lung cancer harboring the KRAS G12C "
• A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants Ended
  2024-518696-65-00 3 2025-08-12 "(HR) -positive human epidermal growth factor receptor 2 (HER"

Showing 145–168 of 234 trials